UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

UBC Offers Patient Recruitment & Retention Strategies and Solutions
- December 04, 2017
Whether it’s working, shopping, banking, traveling, or tackling a host of other responsibilities, we’re all looking for convenience so we can spend more time doing what we love. Clinical trial participants are no different. When it...
- November 27, 2017
Express Scripts (NASDAQ: ESRX) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts...
The NORD Rare Summit brings together stakeholders from across the rare disease community.
Shazia Ahmad, Director, Patient & Physician Services - November 02, 2017
I look forward to the NORD Rare Summit each year.   It is a time to reflect on the work all of us do in the rare disease community−whatever area we work in, be it drug development, clinical research, regulatory compliance or...
UBC Pathways is helping patients access medications faster
Ron Lacy, Senior Director, Healthcare Analytics and Technology - October 24, 2017
It’s been just about a year since UBC launched UBC Pathways, our proprietary suite of healthcare analytics and technology solutions that help patients access their medications as quickly as possible and stay adherent to their therapy...
- October 13, 2017
If you haven’t noticed UBC in the news lately, you may not be looking hard enough. Our experts have been busy talking to media in the industry, sharing insights you don’t want to miss. Here are articles published this month with...

Pages